Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00932893 |
|---|---|
| Brief Title: | An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene |
| First Submitted : | June 30, 2009 |
| First Submitted that Met QC Criteria : | July 2, 2009 |
| First Posted : | July 3, 2009 (Estimate) |
| Results First Submitted : | March 13, 2013 |
| Results First Submitted that Met QC Criteria : | June 4, 2013 |
| Results First Posted : | June 6, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 31, 2016 |
| Last Update Posted : | January 2, 2017 (Estimate) |